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ABSTRACT 
Years ago, it was thought that a genetic component was the fundamental cause of a number retinopathy 
diseases including age related macular degeneration (AMD). Since then, information has emerged about 
novel genes that contribute to various forms of AMD and other retinopathies that have been eluding 
researchers for years.  In the genetic sense, only the APOE 2 and 4 genes have been found to be a risk 
factor for sporadic AMD. But, a recent Genome wide association study (GWAS) revealed that an alteration 
of five SNIPs on the X chromosome in a gene named DIAPH2 may be a susceptibility gene for AMD. 
Furthermore, the gene DIAPH2 showed to have a polygenic pleiotropy for premature ovarian failure (POF) 
and AMD in a cohort of women. POF is highly associated with X chromosome skewing, an epigenetic 
alteration of the inactivation process of the X chromosome.  These findings suggest a hypothesis that an 
epigenetic alteration on the inactivation centres of the X chromosome (or skewing) relates not only to 
aging, but might be a novel property that affects women with AMD more often than men.  
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INTRODUCTION 
The human X chromosome is unique and its uniqueness 
is based on the fact that 5% of the human genome is 
concentrated on the X chromosome and that the 
duplication of this genetic material in women demands 
systematic compensation of the gene dosage in order to 
silence one the copy of the X chromosome [1] . Age 
Related Macular degeneration (AMD) is the most 
prevalent form of retinopathy in the elderly. 
Furthermore, there is a slight prevalence of female 
susceptibility to AMD [2,3] suggesting the involvement of 
the X chromosome. In AMD, the X chromosome is not 
prevalent in comparison to other chromosomes [4] but 
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as we shall encounter, a possible role in epigenetic 
control of X chromosome inactivation might be 
considered as a novel pathway in AMD pathogenesis.  
Two basic forms of AMD have been the focus of research 
[4-6]. Central geographic atrophy is referred to the "dry" 
form of advanced AMD. This form results from atrophy of 
the retinal pigment epithelial layer below the retina, 
which causes vision loss through loss of photoreceptors 
(rods and cones) in the central part of the eye. The other 
form is names "wet" or neovascular/exudative AMD 
which is related to abnormal vessel growth in the 
choriocapillaris through the Bruch’s membrane, leading 
to a leakage of protein and blood in the macula [5-6]. 
These two forms account for almost 2 million people in 
the US alone and seven million people at risk [6]. With 
today’s increased life expectancy, this devastating 
disease will continue to have a significant public health 
impact on the quality of life worldwide [6]. 
Epidemiological studies provide a conclusion of a strong 
interplay of epigenetic, genetic and environmental 
factors in AMD pathogenesis [7]. At present, aging [7,8], 
chronic oxidative stress [9], inflammation [10], vascular 
disease [11], UV exposure [12], nutritional status [13],  
altered fatty acid metabolism [14], are strongly linked to 
AMD [15]  suggesting that AMD etiology is known to be 
multifactorial, i.e., in addition to a strong genetic 
component. Still, advanced age and family history are the 
two major risk factors [16]. To understand AMD in the 
context of aging we will address the X chromosome not 
to its genetic alterations but its unique epigenetic 
properties to manifest inactivation of one of its X 
chromosomes in women and also its relation to skewing 
which may also affect male subjects [17].  
 
X linked genetics in retinopathies and AMD 
The X chromosome harbors a number of disease loci that 
affect the retina, including cone dystrophy (COD1 and 
COD2), juvenile retinoschisis (XLRS), congenital stationary 
night blindness (CSNB), and at least five loci for retinitis 
pigmentosa (Table 1, ref [18, 19-35]). Still, a number of 
gens have been cloned and mapped that of macular 
degeneration, but not for the X chromosome, except 
some deletions in green and red color genes at Xq28 
(Table 1) [34-35]. Families affected by these X 
chromosome deletions reveal progressive cone 
dystrophy and unusual cases with progressive macular 
atrophy in families with blue cone monochromacy (Table 
1) [34-35]. The uniqueness of the X chromosome is 
addressed as not to its loci that harbor genetic changes 
linked to AMD (Table 1) but also a strong link to 
epigenetic mechanisms that may influence the genetic 
component in AMD (Figure 1). 
 
Epigenetics of AMD, relation to X chromosome? 
A number of retinopathy genes have been identified and 
characterized (Table 1) and also recent GWAS analysis 
has broadened our knowledge of the complexity of the 
disease [36]. Using GWAS as stated, recently 5 SNIPs are 
found related to susceptibility to AMD with a slight 
gender preference [3]. However, for many diseases, 
including AMD, the  variation in phenotype with a single 
genotype, individual susceptibility to disease, different 
findings in monozygotic twins, polygenic pleitropy, its 
age-related onset cannot be explained only by acquiring 
mutations in genes or chromosome aberrations alone 
[37]. There must be another layer of information (Figure 
1). This missing link could be epigenetic factors [37-38]. A 
vast spectrum of epigenetic changes has been described. 
The most common epigenetic variations involve DNA 
methylation, various modifications of histones, 
chromatin remodeling, microRNA (miRNA) and small 
non-coding RNA expression [37-38]. Epigenetics are 
involved in gene expression in eye development [38].   
Epigenetic mechanisms influence gene expression and 
function without modification of the base sequence of 
DNA and may be reversible, heritable, and influenced by 
the environment [38-39].  Epigenetics are intertwined 
with environmental factors such as nutrition, smoking, 
pollution and may express genes that are not normally 
triggered, therefore increasing disease susceptibility, 
phenotypic variation and age related progression of 
many common diseases including AMD, glaucoma, 
Alzheimer’s disease [39]. Lin et al [40] revealed that 
inflammation that is associated with glycation end 
products (AGEs) stimulates inflammatory genes in RPE 
cells in vitro leading to the conclusion that there is not 
only a complex interplay of environmental factors with 
our genes but we must account our epigenome to the 
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Figure 1.  AMD is shown to be a consequence of a complex process of 
intertwining genetic, epigenetic and environmental factors with aging 
 
A good example is found in twin studies. Seddon et al 
reported a difference between two twins [41]. One twin 
has been found to have a large drusen and pigmentation 
area accompanied with an advanced stage of AMD and 
these findings where related to heavy smoking. The 
other twin had smaller drusen size and area, and less 
pigmented. In his nutrition he tended to have higher 
dietary vitamin D or methionine intake. These findings 
suggest factors that are associated with epigenetic 
mechanisms are involved in the etiology of AMD, in 
addition to genetic susceptibility [40-42]. These 
epigenetic changes may be age-related and cell or tissue 
specific. They may also persist throughout the lifetime of 
an individual. An understanding of the role of epigenetics 
is important to the success of the stem cell-based 
therapies [42-44]. Our hypothesis is that the X 
chromosome has a more important role than it is noted 
today, in an epigenetic way. By the notion that the same 
genes that are responsible for genetic inheritance for 
AMD are also stimulated by an appropriate 
environmental factor that relates to AGEs and that 
inflammation is a key factor to AMD susceptibility may 
show a mechanistic pathway of how genes on the X 
chromosome may be influenced by alterations of X 





Table 1. X chromosome linked Retinopathies 
* X chromosome ideogram based on G-bands with approximate 





Affected protein, diseases and comments Ref. 
Xp22.2 
 
Jobert syndrome; X-linked retinitis 
pigmentosa, severe;  genomic next-
generation sequencing also uncovered a 
deep intronic mutation in a family with 
severe X-linked RP (the RP23 locus) 
[18] 
Xp21.33 AMD and premature ovarian failure, near the 
DIAPH2 gene, which is known to cause 




Retinoschisis; protein: retinoschisin 
expression is limited to photoreceptors but 
protein is secreted into the inner retina 
[19] 
Xp21-q21 Retinitis pigmentosa with mental retardation [20] 
Xp21.3-p21.2/ 
Xp11.4 
X-linked retinitis pigmentosa 
retinitis pigmentosa GTPase regulator 
[21- 
22] 
Xp21.2-p21.1 Oregon eye disease, candidate gene; exons 





X-linked congenital stationary night 










X-linked progressive cone-rod dystrophy; 





protein: retinitis pigmentosa 2 (X-linked)  [29] 
Xq21.1 
 





optic atrophy, protein: inner mitochondrial 
membrane translocase 8 homolog A., protein 





X-linked retinitis pigmentosa [32] 
Xq27 
 
X-linked progressive cone dystrophy, genetic 








Rare macular dystrophy in blue and red cone 
monochromacy with loss of locus control 
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HYPOTHESIS 
We postulate a hypothesis of an epigenetic influence on 
the inactivation patterns of chromosome X in the 
pathogenesis of AMD. These changes of the inactivation 
patterns are related to skewing. Skewing by definition is 
a non-random X-inactivation process. 
 
Evaluation and Discussion of the Hypothesis: 
Instability in X chromosome inactivation patterns: X 
chromosome skewing 
It has been hypothesized by Lyon in 1961 [45] that one 
the pair of X chromosomes in women is always 
inactivated in early embryonic stage. It is quite clear that; 
inactivation of the X chromosome is a complex 
epigenetic process. This mechanism keeps one individual 
transcriptional active chromosome per cell. In an YXX 
embryo the active chromosome is always the mother’s 
chromosome where the father is always inactivated. By 
the time of implementation of the egg, inactivation is 
erased and re-instated on the basis of randomness in the 
embryo, except for the germinate line where both X 
chromosomes are inactivated and in the placenta where 
only the mother’s X chromosome is expressed.  
Therefore, X chromosome inactivation is a random 
process and it is stably inherited through cell cycling 
which means women universally differ as to which 
chromosome is inactivated. Skewed X chromosome 
inactivation (XCI) is a marked deviation from a 50:50 ratio 
and is arbitrary defined, often as preferential inactivation 
of either maternally or paternally inherited X 
chromosome in 75- 80% or more of cells [46]. 
Skewed X inactivation of one the X chromosomes can 
indicate that there exists some mutations on genes on 
the inactive X chromosome. So, here on the X 
chromosome recessively or dominant inheritance is 
relative because heterozygous women can express a 
phenotype which can be compared to women’s 
phenotypes as a result of X chromosome inactivation 
[46]. Inactive X chromosome acquires a number of 
features of heterochromatin such as hypermetylation, 
hyper condensation, late replication pattern, depletion of 
acetylated histons [46-47]. These characteristics enables 
identification of the inactive X chromosome on the 
cytogenetic level (late replication pattern analysis, 
analysis of Barr body) and molecular level most analyzed 
by using methylation patterns [47,48]. This difference in 
the sensitivity to methylation can be used to analyze 
non-random inactivation processes in diseases that are X 
chromosome linked, determination of tumor clonality 
and iPSC adaptability, i.e.,   iPSC cells show that skewing 
is not random. Initially balanced populations consistently 
skewed toward a “dominant subpopulation,” expressing 
genes from a dominant X allele [43-44]. These cells 
proved to be more efficient in reprogramming, more 
adaptable, than the non-dominant populations. These 
findings indicate that differences in X-linked-associated 
gene function and/or expression levels might influence a 
cell’s ability to deal with various environmental stresses, 
such as DNA damage, and/or affect its replicative life 
span.  
 
A skewed view of X chromosome inactivation in AMD 
A recent new study of the involvement of the X 
chromosome in AMD has been suggested by Jiang et al 
[3] using a simple test for haplotype analysis of the X 
chromosome. This test applies haplotype-sharing (HS) 
statistics with sliding windows for males and females 
separately, which are then combined to a single HS test 
for the X chromosome. It should be noted that the 
haploid test is more powerful than single marker analysis 
[36]. The HS test was applied to genome wide association 
study GWAS of the National Eye Institute: Age Relate Eye 
Study NEI AREDS using 1804 SNPs [3]. What are 
interesting issues in this study are the results that have 
connected premature ovarian failure (POF) with AMD. 
POF is known to have an alteration of inactivation 
process of the X chromosome (skewing). Previous GWAS 
study [7] analyzed 100000 SNPs detected associations. 
Moreover, using the same subset of SNPs, Zheng et al. 
[36] conducted a single marker analysis on 1804 SNPs.  
Jiang et al [3] used a slight different strategy for analysis 
of the X chromosome in GWAS. First they used single 
maker analysis to rank SNPs on the X chromosome and 
the top ranked have been selected for haplotype 
analysis. This haplotype analysis from the GWAS studies 
confirmed risk associations for AMD as former results 
using single markers. Moreover, a chromosomal region 
consisting of five SNIPs has been associated to AMD [36]. 
The new research has found a disease preventive 
haplotype (ATGAC) in this region of SNIPs. These five 
SNPs are covered by the gene DIAPH2, which is known to 
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cause premature ovarian failure (POF) in females. To 
date no relation between POF and AMD has been 
reported, although some relations have been noticed 
between AMD and POF [49-50]. Even though, Bretheric 
et al [51] by using FISH and PCR didn’t find any potential 
regions of DNA addition or deletion in the X 
chromosome, he still suggests that X-chromosome 
abnormalities undetectable by the arrays, or reduced 
follicular pool due to an early trisomic rescue event, may 
explain the skewed XCI observed in POF patients with 
primary amenorrhea. With the work of Baronchelli et al 
[52] these results suggest that a strong genetic factor in 
the etiology of POFis emphasized by the high percentage 
of familial cases in which X chromosome abnormalities 
account for 10% of chromosomal aberrations and that 
these alterations are possibly accompanied by epigenetic 
changes to the X chromosome inactivation patterns, or X 
chromosome skewing. Better said, numerous cases of 
POF in women with X-chromosome deletions or 
translocations have been reported; thus, it is possible 
that smaller rearrangements undetectable by 
conventional cytogenetics may contribute to cells with 
inactivation of the normal X chromosome and may be 
selected against, causing skewed X-chromosome 
inactivation (XCI) in AMD. 
 
Aging and skewing 
X chromosome skewing is affected by the aging process. 
This age-related, acquired XCI skewing can lead to late-
onset disease in individuals, as has been reported for X-
linked sideroblastic anemia [53] however if age-related, 
acquired XCI skewing occurs in tissues other than blood, 
then late-onset symptoms might be a concern for 
additional X-linked disorders which includes a number of 
other diagnosis such as premature ovarian failure, 
scleroderma (an autoimmune disorder), spontaneous 
abortions, a number of cancers, most often breast cancer 
[54]. In some severe X-linked disorders, post-inactivation 
selection takes place against the X chromosome carrying 
the mutant allele, leading to a completely skewed X-
inactivation pattern and may indicate an effect of X-
linked genes on the development of these conditions 
[46,55-56]. What is interesting except X chromosome 
skewing is that no causative X-linked locus has yet been 
identified in such associations, so causes of XCI skewing 
in addition to selection needs to be considered. One view 
supports the model of increased skewing with age as a 
consequence of hematopoietic stem cell senescence 
[57]. The second view suggests age-related skewing is a 
combination of stochastic and genetic events [58].  
All this suggests that the process of X inactivation and the 
resultant degree of skewing is clearly important for the 
expression of diseases with a strong genetic background, 
such as AMD.  
 
CONCLUSION 
The complexity of disease as in AMD shows that no one 
factor can be promoted to the causality of the disease, 
but instead we have to relate to the interplay of 
epigenetic and genetic processes intertwined by 
environmental factors as seen in Figure 1. The X 
chromosome, even though not solely the only intrinsic 
factor in the genetic sense to contribute to AMD, but its  
X-linked genes on the two X chromosomes summons 
such a  genetic variation pool in which  single nucleotide 
polymorphisms(SNPs) and deletions are very common 
and may affect various cellular functions [59]. For 
example, polymorphisms in promoter/enhancer 
sequences might influence gene regulation, whereas 
other SNPs may affect RNA splicing or protein function. 
The findings of five SNPs in in the DIAPH 2 gene 
susceptible to AMD [3] which is also the gene responsible 
of form of POF. POF is known to promote X chromosome 
skewing [52,60-61]. Most of the X-linked genes are not 
involved in sex determination but in various other 
processes such as free radical scavenging, housekeeping, 
apoptosis, cell cycle regulation, tumor suppression [43-
44].  All these processes may have another level of 
activity, good or bad, through the process of X 
chromosome inactivation [62]. Carrel et al [63] observed 
that 15 % of linked genes escape inactivation. Escapees 
are present on active and inactive X chromosomes. This 
shows an unsuspected degree of expression 
heterogeneity among females. X chromosome shows 
also a heritable variation in X-chromosome inactivation 
pattern in normal females [64]. There is genetic effect on 
the imprinting of X-chromosome inactivation in humans. 
Male offspring of females with skewed X-inactivation 
patterns were three times more likely to inherit alleles at 
loci that were located on the inactive X chromosome 
than the active X chromosome [17,64-65] .To broaden 
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this notion, Plenge et al [66] explored skewed X 
chromosome inactivation and X linked mental 
retardation disorders (XLMR) and found that mutation 
carriers demonstrate a strong association with skewed X 
inactivation. The XLMR mutations are present on the 
preferentially inactive X chromosome in all 20 
informative female subjects from these families, 
indicating that skewing is due to selection against those 
cells in which the XLMR mutation is on the active X 
chromosome [66]. 
To our view, the hypothesis of X chromosome instability 
in AMD seen as skewing may be broadened by the view 
that we may have a detrimental effect to DNA repair 
mechanisms in aged subjects by processes of skewing 
and aging. Aging is known to decrease repair of DNA 
damage in the nuclei and in mitochondria [67-68]. So 
skewing and aging may determine the amount of 
accumulated cellular DNA damage. In correspondence to 
Figure 1, DNA damage depends also on environmental 
and/or genetic conditions. These conditions help or 
undermine the cells ability to respond to, and repair 
damaged DNA and to repair telomere shortening. Pomp 
et al. [44] reported that skewing in a heterogeneous 
population of iPSC cells can be alleviated by ectopic 
expression of telomerase, and that this process 
profoundly cooperates in DNA repair.  Another more 
controversial theme is transgenerational epigenetic 
inheritance [69-71]. That is, the environment can stably 
influence the establishment of the epigenome. Together 
with the fact that there is X inactivation inheritance 
pattern suggests that an environmental event in one 
generation could affect the phenotype in subsequent 
generations. Whether there is any merit to these 
assumptions that X chromosome skewing maybe also 
transgenerational inherited and contribute to the cause 
of the complex disease such as AMD is an important 
question to be answered in future research. 
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